Monday, Apr 20, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Natco Pharma Board Okays Acquiring 1 In Canadian Arm

Natco Pharma board okays acquiring 1% in Canadian arm

Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE. 

By PTI
Published Date - 26 March 2021, 05:56 PM
Natco Pharma board okays acquiring 1% in Canadian arm
whatsapp facebook twitter telegram

New Delhi: Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary.

The company, however, did not disclose the value of the deal. “The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma (Canada) Inc., after this acquisition Natco Pharma (Canada) Inc., (will) become a wholly owned subsidiary company of Natco Pharma Ltd,” Hyderabad-based Natco Pharma said in a regulatory filing.


The company did not share any more details. Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE.

  • Follow Us :
  • Tags
  • Canadian subsidiary
  • Hyderabad-based Natco Pharma
  • Natco Pharma
  • regulatory filing

Related News

  • Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

    Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

  • Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

    Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

  • Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

    Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

  • Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

    Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

Latest News

  • Three held in Hyderabad mobile phone snatching case; 10 phones recovered

    25 seconds ago
  • India, New Zealand set to sign landmark FTA in New Delhi

    11 mins ago
  • Silver idol stolen from temple in Secunderabad sparks concern

    15 mins ago
  • Can’t rule out BJP getting two-thirds majority: Rajnath Singh

    18 mins ago
  • VP Radhakrishnan meets Indian-origin Tamil beneficiaries of Indian Housing Project in Sri Lanka

    18 mins ago
  • Mohanlal releases Malayalam’s first musical horror comedy Karakkam’s teaser

    19 mins ago
  • India, South Korea discuss resuming CEPA upgrade talks, boosting cooperation in green energy: Piyush Goyal

    20 mins ago
  • Cyberabad police arrest man for duping women through fake identity, love scam

    20 mins ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

.